Annual Symposium

The Evergrande Center's annual symposium is designed to engage the larger Harvard community in a dialogue about the basis and role of inflammation in multiple human diseases.

Our next symposium will be held on Friday, July 21, 2017 from 9:00 AM - 12:30 PM at the Joseph B. Martin Conference Center at Harvard Medical School. Registration is required.

REGISTER NOW

2017 Symposium Speakers:

Jérôme Galon, PhD, Inserm
Ronald Germain, MD, PhD, National Institutes of Health
Rakesh Jain, MD, Massachusetts General Hospital
Fiona Powrie, PhD, University of Oxford
Shannon Turley, PhD, Genetech

2016 Symposium on Immunity and Inflammation in Disease and Tissue


The third annual Evergrande Center symposium was held on July 15, 2016, in the amphitheater at the Joseph B. Martin Conference Center at Harvard Medical School. Attended by over 500 faculty and students from the Harvard community, the symposium featured talks by James Allison, MD Anderson Cancer Center; Erica Pearce, Ma x Planck Institute if Immunbiology and Epigenetics; Aviv Regev, Broad Institute of of MIT and Harvard; Robert Schreiber, Washington Univeristy School of Medicine; Laurence Zitvogel, Institut Gustave Roussy.

2015 Symposium on Immunity and Inflammation in Disease and Tissue


The second annual Evergrande Center symposium was held on July 17, 2015 and featured talks by Richard Flavell, Yale University School of Medicine; Thomas Gajewski, University of Chicago; Michael Karin, University of California, San Diego; João Pereira, Yale University School of Medicine; Carla Rothlin, Yale University School of Medicine; and John Wherry, University of Pennsylvania.

2014 Symposium on Immunity and Inflammation in Disease and Tissue

Held on August 1, 2014, the first Evergrande Center symposium convened over 200 faculty and students from across Harvard and its affiliates. The day’s presentations showcased the breadth of expertise that will lead and advise the Center as it advances its research and education agenda. Featured speakers provided a glimpse into the diverse approaches that will be supported by the Center, the complexity of the biomedical research programs, and the clear need for a Center of this scope to tackle the wide array of immunologic diseases and disorders.